BRD2 and osteoporosis: A role for FSH in osteoporosis may be through involvement of RANKL-induced osteoclastogenesis as at perimenopausal concentrations (50 mIU/ml) FSH can induce increased RANK expression in peripheral blood mononuclear cells (141).